Silence Therapeutics Statistics

Total Valuation

SLN has a market cap or net worth of $226.16 million. The enterprise value is $53.46 million.

Market Cap	226.16M
Enterprise Value	53.46M

Important Dates

The next confirmed earnings date is Thursday, February 27, 2025, before market open.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

SLN has 47.21 million shares outstanding. The number of shares has increased by 21.51% in one year.

Current Share Class	n/a
Shares Outstanding	47.21M
Shares Change (YoY)	+21.51%
Shares Change (QoQ)	+0.71%
Owned by Insiders (%)	26.46%
Owned by Institutions (%)	37.34%
Float	25.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.72
Forward PS	n/a
PB Ratio	1.79
P/TBV Ratio	1.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.31, with a Debt / Equity ratio of 0.00.

Current Ratio	9.31
Quick Ratio	8.61
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -102.80% and return on invested capital (ROIC) is -63.40%.

Return on Equity (ROE)	-102.80%
Return on Assets (ROA)	-27.27%
Return on Invested Capital (ROIC)	-63.40%
Return on Capital Employed (ROCE)	-38.25%
Revenue Per Employee	$199,754
Profits Per Employee	-$723,788
Employee Count	109
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	-9.47M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.42% in the last 52 weeks. The beta is 1.04, so SLN's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-80.42%
50-Day Moving Average	5.91
200-Day Moving Average	15.00
Relative Strength Index (RSI)	41.32
Average Volume (20 Days)	339,104

Short Selling Information

Short Interest	1.30M
Short Previous Month	1.13M
Short % of Shares Out	2.76%
Short % of Float	5.04%
Short Ratio (days to cover)	3.97

Income Statement

In the last 12 months, SLN had revenue of $21.77 million and -$78.89 million in losses. Loss per share was -$1.79.

Revenue	21.77M
Gross Profit	9.75M
Operating Income	-78.16M
Pretax Income	-52.45M
Net Income	-78.89M
EBITDA	-77.75M
EBIT	-78.16M
Loss Per Share	-$1.79

Full Income Statement

Balance Sheet

The company has $172.89 million in cash and $186,302 in debt, giving a net cash position of $172.70 million or $3.66 per share.

Cash & Cash Equivalents	172.89M
Total Debt	186,302
Net Cash	172.70M
Net Cash Per Share	$3.66
Equity (Book Value)	126.68M
Book Value Per Share	2.68
Working Capital	188.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$58.75 million and capital expenditures -$156,815, giving a free cash flow of -$55.52 million.

Operating Cash Flow	-58.75M
Capital Expenditures	-156,815
Free Cash Flow	-55.52M
FCF Per Share	-$1.18

Full Cash Flow Statement

Margins

Gross Margin	44.78%
Operating Margin	-358.97%
Pretax Margin	-405.85%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SLN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.51%
Shareholder Yield	-21.51%
Earnings Yield	-34.88%
FCF Yield	-24.55%

Analyst Forecast

The average price target for SLN is $46.25, which is 865.55% higher than the current price. The consensus rating is "Buy".

Price Target	$46.25
Price Target Difference	865.55%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SLN has an Altman Z-Score of 2.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.07
Piotroski F-Score	2